Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4349)
All Articles published online
|
Jun 15, 2001 (publication date) through May 13, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zheng CX, Zhan WH, Zhao JZ, Zheng D, Wang DP, He YL, Zheng ZQ. Prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer. World J Gastroenterol 2001; 7(3): 431-434 [PMID: 11819806 DOI: 10.3748/wjg.v7.i3.431] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i3/431.htm |
| Number | Citing Articles |
| 1 |
Soo Young Moon, Jae Myung Cha, Joung Il Lee, Kwang Ro Joo, Hyun Phil Shin, Jae Jun Park, Jung Won Jeon, Jun Uk Lim, Seung Jung Jun, Yoon Jong Seo, Chi Hoon Lee. Preoperative Carbohydrate Antigen 19-9 Levels Can Predict Stage and Survival Rate in Patients with Colorectal Cancer. Intestinal Research 2013; 11(3): 184 doi: 10.5217/ir.2013.11.3.184
|
| 2 |
Huihong Jiang, Erjiang Tang, Dan Xu, Ying Chen, Yong Zhang, Min Tang, Yihua Xiao, Zhiyong Zhang, Xiaxing Deng, Huaguang Li, Moubin Lin. Development and validation of nomograms for predicting survival in patients with non-metastatic colorectal cancer. Oncotarget 2017; 8(18): 29857 doi: 10.18632/oncotarget.16167
|
| 3 |
Jolanda Stiksma, Diana C. Grootendorst, Peter Willem G. van der Linden. CA 19-9 As a Marker in Addition to CEA to Monitor Colorectal Cancer. Clinical Colorectal Cancer 2014; 13(4): 239 doi: 10.1016/j.clcc.2014.09.004
|
| 4 |
Zhe-Yi Han, Kai-Chun Wu, Feng-Tian He, Quan-Li Han, Yong-Zhan Nie, Ying Han, Xiao-Nan Liu, Jian-Yong Zheng, Mei-Hong Xu, Tao Lin, Dai-Ming Fan. Screening and identification of mimotope of gastric cancer associated antigen MGb1-Ag. World Journal of Gastroenterology 2003; 9(9): 1920-1924 doi: 10.3748/wjg.v9.i9.1920
|
| 5 |
Jiangping Fu, Mengjie Tu, Yin Zhang, Yan Zhang, Jiasi Wang, Zhaoping Zeng, Jie Li, Fanxin Zeng. A model of multiple tumor marker for lymph node metastasis assessment in colorectal cancer: a retrospective study. PeerJ 2022; 10: e13196 doi: 10.7717/peerj.13196
|
| 6 |
José Roberto Martins de Souza, José Eduardo Gonçalves, Leandro Luongo Matos, Ana Maria Amaral Antonio Mader, Vera Luiza Capelozzi, Jaques Waisberg. Níveis séricos pré-operatórios dos marcadores CEA e CA19-9 e imunoexpressão tecidual do marcador CA19-9 no carcinoma colorretal: relação com os aspectos morfológicos da neoplasia. Revista do Colégio Brasileiro de Cirurgiões 2010; 37(2): 106 doi: 10.1590/S0100-69912010000200007
|
| 7 |
Bin Xiong, Hong-Yin Yuan, Ming-Bo Hu, Feng Zhang, Zheng-Zhuan Wei, Ling-Ling Gong, Guo-Liang Yang. Transforming growth factor-β1 in invasion and metastasis in colorectal cancer. World Journal of Gastroenterology 2002; 8(4): 674-678 doi: 10.3748/wjg.v8.i4.674
|
| 8 |
Hyeon Yu, Gyung-Mo Son, Yong-Geul Joh. The clinical significance of preoperative serum levels of carbohydrate antigen 19-9 in colorectal cancer. Journal of the Korean Surgical Society 2013; 84(4): 231 doi: 10.4174/jkss.2013.84.4.231
|
| 9 |
Jiqing Li, Jianhua Gu, Xiaotian Ma, Xiao Li, Xiaojuan Liu, Fengling Kang, Fuzhong Xue. Development and validation of a nomogram for predicting survival in Chinese han patients with resected colorectal cancer. Journal of Surgical Oncology 2018; 118(6): 1034 doi: 10.1002/jso.25213
|
| 10 |
Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence. Colorectal Disease 2005; 7(4): 382 doi: 10.1111/j.1463-1318.2005.00773.x
|
| 11 |
Ziba Veisi Malekshahi, Jafar Amani, Babak Negahdari, Masoumeh Rajabibazl, Walead Ebrahimizadeh. Design, expression and evaluation of novel chimeric protein constructed from colorectal tumor‐associated antigen. Journal of Cellular Biochemistry 2018; 119(4): 3464 doi: 10.1002/jcb.26518
|
| 12 |
Jai Hyuen Lee. Clinical Usefulness of Serum CYFRA 21–1 in Patients with Colorectal Cancer. Nuclear Medicine and Molecular Imaging 2013; 47(3): 181 doi: 10.1007/s13139-013-0218-4
|
| 13 |
Fatih Selcukbiricik, Ahmet Bilici, Deniz Tural, Sibel Erdamar, Ozlem Soyluk, Evin Buyukunal, Fuat Demirelli, Suheyla Serdengecti. Are high initial CEA and CA 19–9 levels associated with the presence of K-ras mutation in patients with metastatic colorectal cancer?. Tumor Biology 2013; 34(4): 2233 doi: 10.1007/s13277-013-0763-6
|
| 14 |
Wa Zhong, Zhong Yu, Jun Zhan, Tao Yu, Ying Lin, Zhong-Sheng Xia, Yu-Hong Yuan, Qi-Kui Chen. Association of Serum Levels of CEA, CA199, CA125, CYFRA21-1 and CA72-4 and Disease Characteristics in Colorectal Cancer. Pathology & Oncology Research 2015; 21(1): 83 doi: 10.1007/s12253-014-9791-9
|
| 15 |
Souad S. Youssef, Pullatikurthi Pradeep Kumar. Jaundice Secondary to Isolated Porta Hepatis Metastasis in Colorectal Cancer: Case Report and Review of the Literature. Southern Medical Journal 2004; 97(3): 287 doi: 10.1097/01.SMJ.0000076707.95919.23
|
| 16 |
Jiqing Li, Jianhua Gu, Yuan Lu, Xiaoqing Wang, Shucheng Si, Fuzhong Xue. Development and validation of a Super learner-based model for predicting survival in Chinese Han patients with resected colorectal cancer. Japanese Journal of Clinical Oncology 2020; 50(10): 1133 doi: 10.1093/jjco/hyaa103
|
| 17 |
Xing-Lei Qin, Zuo-Ren Wang, Jing-Sen Shi, Min Lu, Lin Wang, Quan-Ru He. Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: In comparison with CEA. World Journal of Gastroenterology 2004; 10(3): 427-432 doi: 10.3748/wjg.v10.i3.427
|
| 18 |
Bao-Ping Wu, Bing Xiao, Tian-Mo Wan, Ya-Li Zhang, Zhen-Shu Zhang, Dian-Yuan Zhou, Zhuo-Sheng Lai, Chun-Fang Gao. Construction and selection of the natural immune Fab antibody phage display library from patients with colorectal cancer. World Journal of Gastroenterology 2001; 7(6): 811-815 doi: 10.3748/wjg.v7.i6.811
|
| 19 |
Hasan Esad YAYIN, Esranur YAYIN, Sibel BEKTAŞ, Doğan GÖNÜLLÜ, Okcan BASAT. The relationship between preoperative CA 19-9 and CEA levels and histopathology of tumor in colorectal cancer. Journal of Contemporary Medicine 2023; 13(3): 534 doi: 10.16899/jcm.1213936
|
| 20 |
Li-Zong Shen, Wen-Xi Wu, De-Hua Xu, Zhong-Cheng Zheng, Xin-Yuan Liu, Qiang Ding, Yi-Bing Hua, Kun Yao. Specific CEA-producing colorectal carcinoma cell killing with recombinant adenoviral vector containing cytosine deaminase gene. World Journal of Gastroenterology 2002; 8(2): 270-275 doi: 10.3748/wjg.v8.i2.270
|
| 21 |
Jung Kyong Shin, Hee Cheol Kim, Woo Yong Lee, Seong Hyeon Yun, Yong Beom Cho, Jung Wook Huh, Yoon Ah Park, Ho-Kyung Chun. High preoperative serum CA 19-9 levels can predict poor oncologic outcomes in colorectal cancer patients on propensity score analysis. Annals of Surgical Treatment and Research 2019; 96(3): 107 doi: 10.4174/astr.2019.96.3.107
|
| 22 |
Houxi Xu, Hongqun Zhang, Songxian Sun, Jingyuan Zhang, Jiege Huo, Chunxiang Zhou. Downregulation of NAT1 Expression is Associated with Poor Prognosis and Immune Infiltration in COAD. Pharmacogenomics and Personalized Medicine 2024; : 133 doi: 10.2147/PGPM.S455490
|
| 23 |
Andrey D. Dolbnya, Igor A. Popov, Stanislav I. Pekov. Molecular Biomarkers in Cholangiocarcinoma: Focus on Bile. Current Topics in Medicinal Chemistry 2024; 24(8): 722 doi: 10.2174/0115680266290367240130054142
|
| 24 |
Chih‐Ching Wu, Hua‐Chien Chen, Su‐Jen Chen, Hao‐Ping Liu, Yi‐Yueh Hsieh, Chia‐Jung Yu, Reiping Tang, Ling‐Ling Hsieh, Jau‐Song Yu, Yu‐Sun Chang. Identification of collapsin response mediator protein‐2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. PROTEOMICS 2008; 8(2): 316 doi: 10.1002/pmic.200700819
|
| 25 |
Abdullah Sisik, Mustafa Kaya, Gurhan Bas, Fatih Basak, Orhan Alimoglu. CEA and CA 19-9 are Still Valuable Markers for the Prognosis of Colorectal and Gastric Cancer Patients. Asian Pacific Journal of Cancer Prevention 2013; 14(7): 4289 doi: 10.7314/APJCP.2013.14.7.4289
|
| 26 |
Lian-Xin Liu, Wei-Hui Zhang, Hong-Chi Jiang, An-Long Zhu, Lin-Feng Wu, Shu-Yi Qi, Da-Xun Piao. Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer. World Journal of Gastroenterology 2002; 8(4): 663-667 doi: 10.3748/wjg.v8.i4.663
|
| 27 |
Zuojing Yin, Xinmiao Yan, Qiming Wang, Zeliang Deng, Kailin Tang, Zhiwei Cao, Tianyi Qiu. Detecting Prognosis Risk Biomarkers for Colon Cancer Through Multi-Omics-Based Prognostic Analysis and Target Regulation Simulation Modeling. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00524
|
| 28 |
Jiqing Li, Xiao Li, Jianhua Gu, Xiaotian Ma, Fuzhong Xue. A competing-risks nomogram for predicting probability of death from CRC in Chinese Han patients with Stage I–III CRC. Japanese Journal of Clinical Oncology 2018; 48(12): 1088 doi: 10.1093/jjco/hyy136
|
| 29 |
Suguru Ogata, Fumihiko Fujita, Kenji Fujiyoshi, Tomoya Sudou, Takefumi Yoshida, Kenichi Koushi, Kenta Murotani, Shinichi Yamauchi, Kenichi Sugihara, Yoshito Akagi. Prognostic Value of Preoperative Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 Levels for Adjuvant Chemotherapy in Stage II Colorectal Cancer: A Nationwide Multicenter Retrospective Study. Journal of the Anus, Rectum and Colon 2022; 6(4): 249 doi: 10.23922/jarc.2022-020
|
| 30 |
Zhen-Qiang Sun, Shuai Ma, Quan-Bo Zhou, Shuai-Xi Yang, Yuan Chang, Xiang-Yue Zeng, Wei-Guo Ren, Fang-Hai Han, Xiang Xie, Fan-Ye Zeng, Xian-Tao Sun, Gui-Xian Wang, Zhen Li, Zhi-Yong Zhang, Jun-Min Song, Jin-Bo Liu, Wei-Tang Yuan. Prognostic value of lymph node metastasis in patients with T1-stage colorectal cancer from multiple centers in China. World Journal of Gastroenterology 2017; 23(48): 8582-8590 doi: 10.3748/wjg.v23.i48.8582
|
| 31 |
Ziyi Guo, Chenchen Zhuang, Yihang Song, Joel Yong, Yi Li, Zhong Guo, Biao Kong, John M. Whitelock, Joseph Wang, Kang Liang. Biocatalytic Buoyancy-Driven Nanobots for Autonomous Cell Recognition and Enrichment. Nano-Micro Letters 2023; 15(1) doi: 10.1007/s40820-023-01207-1
|
| 32 |
Jing Bian, Bo Li, Xian-Juan Kou, Tian-Zhou Liu, Liang Ming. Clinical Significance of Combined Detection of Serum Tumor Markers in Diagnosis of Patients with Ovarian Cancer. Asian Pacific Journal of Cancer Prevention 2013; 14(11): 6241 doi: 10.7314/APJCP.2013.14.11.6241
|
| 33 |
Toru Yamada, Yoshitsugu Nakanishi, Keisuke Okamura, Takahiro Tsuchikawa, Toru Nakamura, Takehiro Noji, Toshimichi Asano, Kimitaka Tanaka, Yo Kurashima, Yuma Ebihara, Soichi Murakami, Toshiaki Shichinohe, Tomoko Mitsuhashi, Satoshi Hirano. Impact of serum carbohydrate antigen 19‐9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma. Journal of Gastroenterology and Hepatology 2018; 33(9): 1626 doi: 10.1111/jgh.14124
|
| 34 |
Zhao-Cai Yu, Jie Ding, Bo-Rong Pan, Dai-Ming Fan, Xue-Yong Zhang. Expression and bioactivity identification of soluble MG<sub>7</sub> scFv. World Journal of Gastroenterology 2002; 8(1): 99-102 doi: 10.3748/wjg.v8.i1.99
|
| 35 |
Byong Ku Bae, Seong Woo Hong, Yeo Goo Chang, Koo Yong Hahn, In Wook Paik, Hyucksang Lee. Prognostic Value of Preoperative Serum Levels of CEA and CA19-9 in Patients with Colorectal Cancer. Journal of the Korean Society of Coloproctology 2007; 23(5): 338 doi: 10.3393/jksc.2007.23.5.338
|
| 36 |
Do Hyoung Lim, Jai Hyuen Lee, Jong Wan Kim. Feasibility of CYFRA 21‐1 as a serum biomarker for the detection of colorectal adenoma and advanced colorectal adenoma in people over the age of 45. Journal of Clinical Laboratory Analysis 2018; 32(1) doi: 10.1002/jcla.22163
|
| 37 |
Ali Zare, Mahmood Mahmoodi, Kazem Mohammad, Hojjat Zeraati, Mostafa Hosseini, Kourosh Holakouie Naieni. Assessing Misdiagnosis of Relapse in Patients with Gastric Cancer in Iran Cancer Institute Based on a Hidden Markov Multi-state Model. Asian Pacific Journal of Cancer Prevention 2014; 15(9): 4109 doi: 10.7314/APJCP.2014.15.9.4109
|
| 38 |
Ali E. Atici, Tebessum Cakir, Enver Reyhan, Mustafa Duman, Ilter Ozer, Murat Ulas, Erdal B. Bostanci. Preoperative Use of PET/CT in Patients With Colorectal and Gastric Cancer and Its Impact on Treatment Decision Making. International Surgery 2016; 101(7-8): 318 doi: 10.9738/INTSURG-D-16-00006.1
|
| 39 |
Lei Shen, Hai-Xia Li, He-Sheng Luo, Zhi-Xiang Shen, Shi-Yun Tan, Jie Guo, Jun Sun. CDw75 is a significant histopathological marker for gastric carcinoma. World Journal of Gastroenterology 2004; 10(11): 1682-1685 doi: 10.3748/wjg.v10.i11.1682
|
| 40 |
Leilani Lakemeyer, Silvia Sander, Mathias Wittau, Doris Henne-Bruns, Marko Kornmann, Johannes Lemke. Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer. Diseases 2021; 9(1): 21 doi: 10.3390/diseases9010021
|
| 41 |
Jing Xiang, Hanbing Xu, Suresh Pokharel, Jiqing Li, Fuzhong Xue, Ping Zhang. Building a knowledge base for colorectal cancer patient care using formal concept analysis. BMC Medical Informatics and Decision Making 2022; 21(S11) doi: 10.1186/s12911-021-01728-y
|
| 42 |
Dongbing Ding, Yao Yao, Changming Yang, Songbai Zhang. Identification of mannose receptor and CD163 as novel biomarkers for colorectal cancer. Cancer Biomarkers 2018; 21(3): 689 doi: 10.3233/CBM-170796
|